|IBBR awarded NIH grant to investigate body’s T-cell mechanism of attack||
New approaches hope to give researchers a glimpse into the cell’s “alert system” to fight tumors and viruses
|NIST-IBBR Researchers Awarded Department of Commerce Gold Medal for developing the NISTmAb Standard||
|IBBR Receives Grant to Explore Next Generation Multi-Specific Antibody Therapeutic: Next Step towards a Cure for HIV?||
The goal is to develop and test a “first-in-class multi-specific antibody“, which could offer dramatic advantages over current treatments for AIDS patients, help eliminate hidden reservoirs of HIV, and potentially deliver on the promise of a long-awaited HIV cure.
|Montgomery County High School Interns Showcase Their Achievements||
Local students complete a biotechnology summer internship program and present their research projects in a poster session.
|Exploring Biomedical Applications of Multifunctional Polyphosphazenes||
Renowned IBBR chemist to speak at the American Chemical Society National Meeting
|Decade of TMV research leads to never-before-seen microsystems for energy storage, biosensors and self-sustaining systems||
Since 2007, University of Maryland professors Reza Ghodssi (Electrical and Computer Engineering and Institute for Systems Research) and James Culver (Plant Sciences and Landscape Architecture and Institute of Bioscience and Biotechnology Research) have partnered with colleagues from materials science, chemistry and bioengineering to create devices using the Tobacco mosaic virus as a biological nanoscaffold.
|IBBR Awarded $6 Million NIH Grant for Structure-Based Design of a Hepatitis C Vaccine||
(Rockville, MD, June 12, 2017) University of Maryland’s Institute for Bioscience and Biotechnology Research (IBBR) has been awarded a $6.0 million grant entitled, “Structure-Based Vaccine Design for Hepatitis C Virus”, to develop a novel prophylactic vaccine to prevent hepatitis C virus (HCV) infection. The grant is funded by the National Institutes of Health (NIH) and the research will take place over a five-year period.
|IBBR faculty win two Maryland Innovation Initiative (MII) grants||
(Rockville, Maryland) The Institute for Bioscience and Biotechnology Research (IBBR) has been awarded two $115,000 grants to commercialize technologies based on improving protein-based therapeutics utilizing a novel biopolymer and an alternate way to treat Niemann-Pick disease patients. The grants are funded by the Maryland Innovation Initiative (MII) as part of the Technology Council of Maryland’s (TEDCO) effort to support commercialization of academic-based scientific research and the state’s efforts to foster economic development in Maryland.
|Genisphere Begins Collaborative and Sponsored Research Program with the University of Maryland||
HATFIELD, Pa - April 26, 2017 - Genisphere LLC, provider of the 3DNA® drug delivery platform, has signed a collaborative and sponsored research agreement with the University of Maryland, through Dr. Silvia Muro. The overall goal of the partnership is to study the pharmacokinetics and pharmacodynamics of various 3DNA designs and formulations after in vivo administration.
|IBBR Receives Award to Develop Drought-Tolerant Plants||
(Rockville, Maryland) The Institute for Bioscience and Biotechnology Research has been awarded a $100,000 grant to test the broader applicability of a technology platform invented by one of its leading scientists towards engineering drought-tolerant, agriculturally important crops. The grant is funded by the Maryland Innovation Initiative (MII) as part of the Technology Council of Maryland’s (TEDCO) effort to support commercialization of academic-based scientific research as part of the state’s efforts to foster economic development in Maryland.